The problem is that the LH trial is only 50 patients, and If I remember correctly, it's a PH II trial. I would imagine even if we show superb results, with such a small group of participants and it being PH II, we are still going to have to replicate those results in a much larger PH III trial. Remember, LH's isn't deadly, but it certainly affects quality of life. So if takes 3 months for this PH II, how much longer will a PH III take? We may be talking about the end of the year before we could see an approval IMO.